Association of superficial macular vessel density with visual field progression in open-angle glaucoma with central visual field damage.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
03 05 2023
03 05 2023
Historique:
received:
22
12
2022
accepted:
22
04
2023
medline:
5
5
2023
pubmed:
4
5
2023
entrez:
3
5
2023
Statut:
epublish
Résumé
Identifying the clinical relevance of superficial versus deep layer macular vessel density (mVD) in glaucoma is important for monitoring glaucoma patients. Our current retrospective longitudinal study investigated the association of superficial and deep layer mVD parameters with glaucomatous visual field (VF) progression in mild to moderate open-angle glaucoma (OAG) eyes with central visual field (CVF) damage. Serial optical coherence tomography (OCT) angiography-derived mVD measurements were obtained in 182 mild to moderate OAG eyes (mean deviation ≥ -10 decibels). Forty-eight eyes (26.4%) showed VF progression during a mean follow-up of 3.5 years. The parafoveal and perifoveal mVDs of both superficial and deep layers showed significantly faster reduction rates in the VF progressors than in the non-progressors according to linear mixed effects models (P < 0.05). Cox and linear regression analyses showed that greater reduction rates of both the superficial layer parafoveal and perifoveal mVDs, but not their deep layer counterparts, were significant predictors of VF progression and faster VF loss (P < 0.05). In conclusion, faster rates of change in superficial but not deep layer mVD parameters are significantly associated with subsequent VF progression and faster VF deterioration in mild to moderate OAG eyes with CVF damage.
Identifiants
pubmed: 37137927
doi: 10.1038/s41598-023-34000-6
pii: 10.1038/s41598-023-34000-6
pmc: PMC10156675
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
7190Informations de copyright
© 2023. The Author(s).
Références
Sci Rep. 2019 Nov 14;9(1):16813
pubmed: 31728047
J Ophthalmol. 2017;2017:1480746
pubmed: 28815087
Korean J Ophthalmol. 2015 Apr;29(2):102-8
pubmed: 25829826
Graefes Arch Clin Exp Ophthalmol. 2018 Aug;256(8):1499-1508
pubmed: 29637255
Am J Ophthalmol. 2022 May;237:241-258
pubmed: 34902325
Ophthalmology. 2020 Aug;127(8):1043-1052
pubmed: 32085875
Am J Ophthalmol. 2021 Jun;226:137-147
pubmed: 33524366
Ophthalmology. 2015 Nov;122(11):2252-60
pubmed: 26278860
Am J Ophthalmol. 2022 May;237:193-203
pubmed: 34801510
Br J Ophthalmol. 2022 Sep;106(9):1252-1257
pubmed: 33737306
Ophthalmology. 2012 Jun;119(6):1151-8
pubmed: 22365056
Transl Vis Sci Technol. 2019 Sep 11;8(5):2
pubmed: 31555493
PLoS One. 2015 May 15;10(5):e0127233
pubmed: 25978316
Ophthalmology. 1998 Feb;105(2):224-31
pubmed: 9479279
Ophthalmology. 2017 Nov;124(11):1589-1599
pubmed: 28676279
J Glaucoma. 2020 Feb;29(2):104-111
pubmed: 31764579
Am J Ophthalmol. 2014 Dec;158(6):1318-1329.e3
pubmed: 25194230
Invest Ophthalmol Vis Sci. 2017 Oct 1;58(12):5548-5555
pubmed: 29075766
Ophthalmology. 2014 Jan;121(1):93-99
pubmed: 23962652
Arch Ophthalmol. 1993 Jun;111(6):831-6
pubmed: 8512486
Invest Ophthalmol Vis Sci. 2018 Aug 1;59(10):4143-4153
pubmed: 30105369
Am J Ophthalmol. 2018 Mar;187:92-98
pubmed: 29317211
Invest Ophthalmol Vis Sci. 2016 Jul 1;57(9):OCT451-9
pubmed: 27409505
Sci Rep. 2018 Oct 30;8(1):16009
pubmed: 30375515
Graefes Arch Clin Exp Ophthalmol. 2018 Mar;256(3):589-597
pubmed: 29332249
Br J Ophthalmol. 2017 Dec;101(12):1666-1672
pubmed: 28432111
Invest Ophthalmol Vis Sci. 2012 Aug 17;53(9):5728-36
pubmed: 22836777
J Glaucoma. 2021 Jun 1;30(6):e276-e284
pubmed: 33899812
Graefes Arch Clin Exp Ophthalmol. 2017 Jun;255(6):1193-1202
pubmed: 28429123
Ophthalmology. 2017 May;124(5):709-719
pubmed: 28196732
Arch Ophthalmol. 2002 Dec;120(12):1636-43
pubmed: 12470136
Invest Ophthalmol Vis Sci. 2010 Mar;51(3):1458-63
pubmed: 20042657
Invest Ophthalmol Vis Sci. 2008 May;49(5):1907-15
pubmed: 18436824
Ophthalmology. 2011 Sep;118(9):1782-9
pubmed: 21665283
Ophthalmology. 1999 Nov;106(11):2144-53
pubmed: 10571351
Invest Ophthalmol Vis Sci. 2019 Mar 1;60(4):889-900
pubmed: 30835290
J Comp Neurol. 1990 Oct 1;300(1):5-25
pubmed: 2229487